5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

• M. Callaghan,
• K.I. Ataga,
• L. De Franceschi,
• C. Minniti,
• N. Balachandran,
• D.-.C. Imbs,
• T. Perretti,
• J. Ramos,
• A. Sostelly,
• P. Bartolucci

Affiliations

M. Callaghan

K.I. Ataga

L. De Franceschi

C. Minniti

N. Balachandran

D.-.C. Imbs

T. Perretti

J. Ramos

A. Sostelly

P. Bartolucci